EG15051A - Pharmaceutical formulations containing a preservatives - Google Patents

Pharmaceutical formulations containing a preservatives

Info

Publication number
EG15051A
EG15051A EG155/81A EG15581A EG15051A EG 15051 A EG15051 A EG 15051A EG 155/81 A EG155/81 A EG 155/81A EG 15581 A EG15581 A EG 15581A EG 15051 A EG15051 A EG 15051A
Authority
EG
Egypt
Prior art keywords
preservatives
pharmaceutical formulations
formulations containing
pharmaceutical
formulations
Prior art date
Application number
EG155/81A
Other languages
English (en)
Inventor
H Marsdon Peter
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of EG15051A publication Critical patent/EG15051A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG155/81A 1980-03-21 1981-03-21 Pharmaceutical formulations containing a preservatives EG15051A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8009589 1980-03-21

Publications (1)

Publication Number Publication Date
EG15051A true EG15051A (en) 1985-06-30

Family

ID=10512277

Family Applications (1)

Application Number Title Priority Date Filing Date
EG155/81A EG15051A (en) 1980-03-21 1981-03-21 Pharmaceutical formulations containing a preservatives

Country Status (30)

Country Link
EP (1) EP0037043B1 (fr)
JP (1) JPS56150012A (fr)
KR (1) KR830004856A (fr)
AU (1) AU542560B2 (fr)
CA (1) CA1168154A (fr)
CS (1) CS261206B2 (fr)
CY (1) CY1361A (fr)
DD (1) DD157535A5 (fr)
DE (1) DE3167270D1 (fr)
DK (1) DK159414C (fr)
EG (1) EG15051A (fr)
FI (1) FI75991C (fr)
GB (1) GB2072015B (fr)
GR (1) GR73038B (fr)
HK (1) HK52787A (fr)
HU (1) HU185630B (fr)
IE (1) IE51035B1 (fr)
IL (1) IL62447A (fr)
IN (1) IN153498B (fr)
IT (1) IT8148073A0 (fr)
MC (1) MC1379A1 (fr)
MY (1) MY8700517A (fr)
NO (1) NO155377C (fr)
NZ (1) NZ196571A (fr)
PH (1) PH17800A (fr)
PL (1) PL138377B1 (fr)
PT (1) PT72703B (fr)
SG (1) SG20787G (fr)
ZA (1) ZA811896B (fr)
ZW (1) ZW6481A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277323A (ja) * 1986-02-19 1987-12-02 Sankyo Co Ltd フマル酸ケトチフエン含有点眼液の製法
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
FR2622112A1 (fr) * 1987-10-27 1989-04-28 Medipro Medicament comprenant l'association de polymyxine b, de neomycine et d'amphotericine b administre par vaporisation
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
WO1991012808A1 (fr) * 1990-02-22 1991-09-05 Macnaught Pty Limited Larmes artificielles
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
HUE038395T2 (hu) 2003-11-20 2018-10-29 Novo Nordisk As Propilén-glikol tartalmú peptidkészítmények, amelyek elõállításra és injekciós eszközökben történõ alkalmazásra optimálisak
WO2009046967A1 (fr) * 2007-10-08 2009-04-16 Fovea Pharmaceuticals Sa Formulations ophtalmiques aqueuses
TWI762706B (zh) 2017-08-24 2022-05-01 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
BR112022013795A2 (pt) 2020-02-18 2022-09-13 Novo Nordisk As Composição farmacêutica líquida, e, kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703777A (en) * 1950-05-02 1955-03-08 Iso Sol Company Inc Ophthalmological preparations and vehicles and method of making the same
GB1340517A (en) * 1969-12-01 1973-12-12 Burton Parsons Chemicals Inc Ophthalmic solution
US3898330A (en) * 1973-08-01 1975-08-05 Squibb & Sons Inc Corticosteroid phosphate salts/neomycin sulfate ophthalmic
NL7416636A (nl) * 1973-12-27 1975-07-01 Wellcome Found Farmaceutisch preparaat.

Also Published As

Publication number Publication date
DK127181A (da) 1981-09-22
CY1361A (en) 1987-08-07
NZ196571A (en) 1983-03-15
MY8700517A (en) 1987-12-31
JPH0148246B2 (fr) 1989-10-18
NO810961L (no) 1981-09-22
PL138377B1 (en) 1986-09-30
FI810870L (fi) 1981-09-22
DD157535A5 (de) 1982-11-17
IT8148073A0 (it) 1981-03-20
GB2072015B (en) 1983-12-21
DK159414B (da) 1990-10-15
SG20787G (en) 1987-07-10
HK52787A (en) 1987-07-17
HU185630B (en) 1985-03-28
IE810617L (en) 1981-09-21
DK159414C (da) 1991-03-18
CS205681A2 (en) 1988-05-16
NO155377B (no) 1986-12-15
IL62447A0 (en) 1981-05-20
CA1168154A (fr) 1984-05-29
GR73038B (fr) 1984-01-26
PL230236A1 (en) 1983-07-04
CS261206B2 (en) 1989-01-12
JPS56150012A (en) 1981-11-20
FI75991B (fi) 1988-05-31
AU6856781A (en) 1981-09-24
IE51035B1 (en) 1986-09-17
PT72703A (en) 1981-04-01
DE3167270D1 (en) 1985-01-03
FI75991C (fi) 1988-09-09
PH17800A (en) 1984-12-13
ZA811896B (en) 1982-10-27
ZW6481A1 (en) 1983-01-19
KR830004856A (ko) 1983-07-20
AU542560B2 (en) 1985-02-28
MC1379A1 (fr) 1982-01-19
NO155377C (no) 1987-03-25
PT72703B (en) 1982-11-15
EP0037043B1 (fr) 1984-11-21
IL62447A (en) 1983-11-30
EP0037043A1 (fr) 1981-10-07
IN153498B (fr) 1984-07-21
GB2072015A (en) 1981-09-30

Similar Documents

Publication Publication Date Title
DE3172028D1 (en) Pharmaceutical formulation
ZA813465B (en) Pharmaceutical composition
ZA814215B (en) Pharmaceutical preparations
ZA81136B (en) Pharmaceutical compositions
EG15051A (en) Pharmaceutical formulations containing a preservatives
IL67336A0 (en) Pharmaceutical composition containing vitamin a
GB2087236B (en) Pharmaceutical preparations containing a 6b-halopenicillanic acid
GB2072504B (en) Pharmaceutical compositions
ZA83130B (en) A pharmaceutical composition
GB2067900B (en) Medicinal tablets
GB2074028B (en) Pharmaceutical formulations
ZA815700B (en) Pharmaceutical compositions
ZA818221B (en) Pharmaceutical compounds
ZW4881A1 (en) Pharmaceutical preparations
PH17121A (en) Pharmaceutical preparations
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
PT73952A (en) Pharmaceutical compositions
IL65976A0 (en) Pharmaceutical compositions comprising a d-homosteroid
SG62587G (en) Pharmaceutical formulation
ZA81919B (en) Pharmaceutical compositions containing a naphyridine derivative
ZA815175B (en) Pharmaceutical composition
PH14593A (en) A pharmaceutical composition incorporating an aryltrifluoroethanol
KE3581A (en) Pharmaceutical formulation
JPS57154128A (en) Medicinal composition
PT73810A (en) Pharmaceutical compositions